Full-Time

Analyst – Equity Investments

PanAgora

PanAgora

Compensation Overview

$120k - $140k/yr

Boston, MA, USA

In Person

Category
Finance & Banking (1)
Required Skills
LLM
Python
SQL
Machine Learning
Data Analysis
Requirements
  • Strong programming and quantitative modeling skills, with the ability to design, implement, and evaluate equity factor models
  • Solid understanding of how companies, industries, and markets function—or a demonstrated willingness and ability to learn quickly
  • Prior exposure to medical, biomedical, pharmaceutical, or life-sciences research (academic, industry, or applied), with the ability to interpret scientific or clinical data
  • Experience conducting empirical research using large datasets and advanced analytical techniques, including machine learning, NLP, and/or large language models
  • Proficiency in Python and SQL, with experience in data analysis and visualization
  • Working knowledge of alpha factor research, forecasting methods, and portfolio construction concepts
  • Intellectual curiosity, creativity, and the ability to blend technical rigor with economic and scientific intuition
  • Excellent written and verbal communication skills, with the ability to clearly explain complex ideas
  • High integrity and a collaborative, team-oriented mindset
  • Formal education is flexible; candidates with advanced graduate degrees in Finance, Economics, Data Science, Engineering, Medicine, or life-sciences–related fields are common, but equivalent skills and experience are equally valued
  • Typically 2–5 years of relevant research or modeling experience, though exceptional candidates outside this range will be considered
Responsibilities
  • Conduct alpha factor research for global equity strategies by generating investment hypotheses and performing rigorous quantitative analysis
  • Apply advanced statistical and modeling techniques, grounded in fundamental insight, to datasets of varying scale; enhance existing models and explore new, data-driven research directions
  • Analyze global equity markets, industry dynamics, and macroeconomic trends to inform business, sector, and market-level forecasts
  • Incorporate domain knowledge—particularly in healthcare, biotechnology, or medical research—into systematic signals and investment models where relevant
  • Translate economic, scientific, and company-level insights into portfolio-relevant inputs
Desired Qualifications
  • Exposure to medical or life-sciences research is a strong plus

Company Size

N/A

Company Stage

N/A

Total Funding

N/A

Headquarters

Boston, Massachusetts

Founded

1989

Simplify Jobs

Simplify's Take

What believers are saying

  • Tim Stanton hired June 2025 as Head of Global Distribution expands reach.
  • Eric Sorensen transitions September 2024 to Vice Chair preserves continuity.
  • Q2 2025 stakes in SITE Centers, Honest, Worthington signal active deployment.

What critics are saying

  • Sorensen's CEO departure erodes confidence, triggers outflows in 6-12 months.
  • Stanton's inexperience stalls inflows from tiny Q2 stakes like $43k Honest.
  • Great-West Lifeco ownership forces divestiture, causes talent exodus in 18-24 months.

What makes PanAgora unique

  • PanAgora specializes as Boston-based quantitative equity boutique manager.
  • George Mussalli promoted to Global CIO leveraging 20-year expertise.
  • Bryan Belton elevated from portfolio manager to President and CEO.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at PanAgora who can refer or advise you

Benefits

Health Insurance

401(k) Retirement Plan

Remote Work Options

Company News

Yahoo Finance
Jun 30th, 2025
PanAgora Welcomes Tim Stanton as Managing Director, Head of Global Distribution

PanAgora welcomes Tim Stanton as Managing Director, Head of Global Distribution.

ETF Daily News
Dec 23rd, 2024
Franklin Resources Inc. Sells 333,165 Shares of SITE Centers Corp. (NYSE:SITC)

Panagora Asset Management Inc. purchased a new stake in SITE Centers in the 2nd quarter worth approximately $3,089,000.

MarketBeat
Dec 23rd, 2024
Barclays PLC Lowers Holdings in Pegasystems Inc. (NASDAQ:PEGA)

Finally, Panagora Asset Management Inc. purchased a new stake in Pegasystems in the 2nd quarter worth $7,599,000.

MarketBeat
Dec 16th, 2024
State Street Corp Decreases Position in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)

Panagora Asset Management Inc. purchased a new stake in Apellis Pharmaceuticals in the 2nd quarter worth approximately $907,000.

MarketBeat
Dec 11th, 2024
72,933 Shares in The Honest Company, Inc. (NASDAQ:HNST) Bought by Walleye Capital LLC

Finally, Panagora Asset Management Inc. acquired a new stake in Honest in the 2nd quarter valued at $43,000.